Bacterial infections affect millions of people every year, and they can strike at any time and for innumerable reasons, including eating tainted food, exposure to the wrong substances and even due to a genetic disposition to be more vulnerable to bacteria as opposed to others who may not be as at-risk for developing such conditions.
The reality is that these infections have spurned research and development efforts by several pharmaceutical companies, and one company in particular, Bristol-Meyers Squibb, formulated a medication that proved to be quite successful after it hit the market. That medication is known as Cefepime, and it has been administered to patients throughout the United States to help treat those bacterial infections.
Cefepime is an anti-biotic medication, which means that it's designed to seek out the bacteria at issue and kill it off before it continues to spread inside a patient's body and cause additional and more serious problems. It is seen as part of the ß–lactams group of anti-biotics, and it's generally administered via injection. Usually, a doctor will administer the first injection of Cefepime, and then the patient will follow instructions and administer subsequent injections on his or her own.
The problem with Cefepime can be traced to a study that was done recently. The results of this study were published by The Lancet Infectious Diseases, a publication that's well-known within the medical community. This journal published an article recently that detailed the statistics of a study involving Cefepime. In general, these statistics were extremely daunting, as they showed a higher tendency of sudden death by those taking this medication than those who were not.
As of now, no definitive cause of this condition has been reached, but the Food and Drug Administration published a warning letter that is meant to be reviewed by all medical professionals. The warning states that the FDA is working in conjunction with Bristol-Meyers Squibb, and will continue to do so for four months in order to come to some sort of conclusion as to the nature of the problem and what can be done to correct it.
If you are taking Cefepime for an infection, the first thing you need to do is contact your doctor to schedule a full evaluation. If you or someone you love had been harmed as a result of this medication, you should also contact a defective drugs attorney immediately to begin the process of evaluating your legal rights and options. You may have a valid cause of action available, but you'll need to make that determination by speaking to your defective drugs attorney and making that decision with the professional help you need.
Begin your case review by filling out the form below or call us 24 hours a day/ 7 days a week at 1-866-242-0905
Our legal staff is standing by to review your potential case. You will be contacted by a member of our staff within 24 hours of submitting your information.
